We believe technology can help improve access and make clinical trial recruitment more efficient.
Check out the tool at www.ancora.ai
📈 High Interest: 91% of cancer patients want to participate (CISCRP).
📉 Severe Leak: Only 20% of interested cancer patients actually get the timely, actionable info needed for a referral.
#patientrecruitment #clinicaltrials
📈 High Interest: 91% of cancer patients want to participate (CISCRP).
📉 Severe Leak: Only 20% of interested cancer patients actually get the timely, actionable info needed for a referral.
#patientrecruitment #clinicaltrials
Our analysis showed a staggering 78% of patient trial requests received NO response from sites OR were for trials that were already closed.
We called this the "Last Mile Leak" with Ken Getz from Tufts CSDD: bit.ly/3KnXcNm
#patientrecruitment #clinicaltrials
Our analysis showed a staggering 78% of patient trial requests received NO response from sites OR were for trials that were already closed.
We called this the "Last Mile Leak" with Ken Getz from Tufts CSDD: bit.ly/3KnXcNm
#patientrecruitment #clinicaltrials
Our data from the ancora.ai #NET Digital Trial Finder exposed a critical breakdown in patient recruitment.
The issue? Patient interest is strong, but the follow-up process is failing them.
#ClinicalTrials #NeuroEndocrineTumors
Our data from the ancora.ai #NET Digital Trial Finder exposed a critical breakdown in patient recruitment.
The issue? Patient interest is strong, but the follow-up process is failing them.
#ClinicalTrials #NeuroEndocrineTumors
Congratulations to the World CUP Alliance on a successful inaugural event & a great kick off to
@myesmo.bsky.social
Congratulations to the World CUP Alliance on a successful inaugural event & a great kick off to
@myesmo.bsky.social
The meeting was an inspiring day full of incredible research & collaboration focused on improving the lives of patients with Cancer of Unknown Primary (CUP).
#cancerunknownprimary
The meeting was an inspiring day full of incredible research & collaboration focused on improving the lives of patients with Cancer of Unknown Primary (CUP).
#cancerunknownprimary
A huge thanks to our incredible expert group of #patient advocates, #physicians, researchers & #biotech as well as our collaborators 5P Health Care Solutions.
Link to tool www.ancora.ai/braintumors
Press release www.ancora.ai/en/newsartic...
A huge thanks to our incredible expert group of #patient advocates, #physicians, researchers & #biotech as well as our collaborators 5P Health Care Solutions.
Link to tool www.ancora.ai/braintumors
Press release www.ancora.ai/en/newsartic...
We're grateful for the opportunity to have presented our newly released Global Radiopharmaceutical Trial Finder powered by Ancora.ai
💫 www.radtrials.com
We're grateful for the opportunity to have presented our newly released Global Radiopharmaceutical Trial Finder powered by Ancora.ai
💫 www.radtrials.com
We're embarking on a mission to expand the Ancora.ai #clinicaltrial finder to include brain tumors.
Our goal is simple: make it easier for #braintumor patients to find & access clinical trials.
We're embarking on a mission to expand the Ancora.ai #clinicaltrial finder to include brain tumors.
Our goal is simple: make it easier for #braintumor patients to find & access clinical trials.